Current neoadjuvant treatment options for HER2 positive breast cancer
Hikmat Abdel-Razeq, Lina MareiSection of Hematology and Medical Oncology, Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanAbstract: Approximately one quarter of patients with breast cancer demonstrate amplification of the human epidermal receptor type 2 (HER2) gene, the exp...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-08-01
|
| Series: | Biologics: Targets & Therapy |
| Online Access: | http://www.dovepress.com/current-neoadjuvant-treatment-options-for-her2-positive-breast-ca-a8042 |